Remote patient Monitoring in adults receiving red blood cell Transfusion for hematological disorders * a Pilot study of the physIQ Real World Monitoring platform using wearable biosensors

Remote patient Monitoring in adults receiving red blood cell Transfusion for hematological disorders * a Pilot study of the physIQ Real World Monitoring platform using wearable biosensors - ReMoT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON50160

Enrollment

Registered

2019-09-24

Start date

2019-12-17

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic anemia myelodysplastic syndrome

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 18 years old or above in need of at least 1 red blood cell transfusion each month

Exclusion criteria

Exclusion criteria: Cardiological conductivity disorder Severe pulmonary comorbidities Known skin allergies Participating in another clinical study

Design outcomes

Primary

Measure	Time frame
- Processed data sets collected from continuous monitoring with the VitalPatch including, but not limited to: heart rate; respiratory rate and activity. - A significant difference in mean heartrate per day before and after transfusion, large enough in comparison to the standard deviation of the mean to power a study with a reasonable sample size (	—

Secondary

Measure	Time frame
- Processed data sets collected from continuous monitoring with the Withings steel HR including, but not limited to: heart rate; respiratory rate and activity. - PROMIS SF Questionnaire - QUALMS Questionnaire - CANTAB RVP Cognitive tool - Amount of RBC units transfused	—

Countries

Netherlands

Outcome results